Champions Oncology Inc (CSBR)
4.76
-0.05
(-1.11%)
USD |
NASDAQ |
May 16, 16:00
4.76
0.00 (0.00%)
After-Hours: 20:00
Champions Oncology Gross Profit Margin (Quarterly): 34.70% for Jan. 31, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| January 31, 2024 | 34.70% |
| October 31, 2023 | 42.82% |
| July 31, 2023 | 38.83% |
| April 30, 2023 | 43.86% |
| January 31, 2023 | 39.72% |
| October 31, 2022 | 47.88% |
| July 31, 2022 | 48.69% |
| April 30, 2022 | 51.69% |
| January 31, 2022 | 51.44% |
| October 31, 2021 | 52.41% |
| July 31, 2021 | 52.05% |
| April 30, 2021 | 44.69% |
| January 31, 2021 | 57.24% |
| October 31, 2020 | 44.21% |
| July 31, 2020 | 44.10% |
| April 30, 2020 | 42.36% |
| January 31, 2020 | 52.01% |
| October 31, 2019 | 49.10% |
| July 31, 2019 | 44.31% |
| April 30, 2019 | 44.27% |
| January 31, 2019 | 46.67% |
| October 31, 2018 | 48.44% |
| July 31, 2018 | 50.47% |
| April 30, 2018 | 42.79% |
| January 31, 2018 | 51.34% |
| Date | Value |
|---|---|
| October 31, 2017 | 49.01% |
| July 31, 2017 | 47.51% |
| April 30, 2017 | 30.89% |
| January 31, 2017 | 32.51% |
| October 31, 2016 | 50.57% |
| July 31, 2016 | 31.25% |
| April 30, 2016 | 17.45% |
| January 31, 2016 | 17.48% |
| October 31, 2015 | 32.31% |
| July 31, 2015 | 19.45% |
| April 30, 2015 | 31.56% |
| January 31, 2015 | -7.98% |
| October 31, 2014 | 8.66% |
| July 31, 2014 | 9.94% |
| April 30, 2014 | 37.39% |
| January 31, 2014 | 56.04% |
| October 31, 2013 | 39.99% |
| July 31, 2013 | 44.67% |
| April 30, 2013 | 15.42% |
| January 31, 2013 | 57.42% |
| October 31, 2012 | 27.50% |
| July 31, 2012 | 30.15% |
| April 30, 2012 | -10.93% |
| January 31, 2012 | 44.53% |
| October 31, 2011 | 37.91% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
34.70%
Minimum
Jan 2024
57.24%
Maximum
Jan 2021
46.43%
Average
44.69%
Median
Apr 2021
Gross Profit Margin (Quarterly) Benchmarks
| AIM ImmunoTech Inc | 81.54% |
| Perspective Therapeutics Inc | -- |
| Protalix BioTherapeutics Inc | 30.58% |
| Electromed Inc | 74.85% |
| Armata Pharmaceuticals Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -417.9% |
| Return on Assets | -31.29% |
| Return on Invested Capital | -417.9% |
| Profit Margin (Quarterly) | -21.05% |
| Operating Margin (Quarterly) | -21.44% |
| Return on Net Operating Assets | -35.95% |